Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

NCT01929408 · clinicaltrials.gov ↗

COMPLETED

Status

703

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
Myelodysplastic Syndrome (MDS)

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]